共 243 条
- [1] Chalasani N(2018)The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases Hepatology 67 328-357
- [2] Younossi Z(2015)Nonalcoholic fatty liver disease: a systematic review JAMA 313 2263-2273
- [3] Lavine JE(2016)Global epidemiology of nonalcoholic fatty liver disease—meta-analytic assessment of prevalence, incidence, and outcomes Hepatology 64 73-84
- [4] Charlton M(1999)Liver biopsy: complications and risk factors World J Gastroenterol 5 301-304
- [5] Cusi K(2018)Noninvasive biomarkers in NAFLD and NASH—current progress and future promise Nat Rev Gastroenterol Hepatol 15 461-478
- [6] Rinella M(2021)Circulating miRNA is a useful diagnostic biomarker for nonalcoholic steatohepatitis in nonalcoholic fatty liver disease Sci Rep 11 14639-552
- [7] Harrison SA(2014)Progress in the search for circulating biomarkers of nonalcoholic fatty liver disease Biomarkers 19 541-1437
- [8] Brunt EM(2020)Multiparametric MR is a valuable modality for evaluating disease severity of nonalcoholic fatty liver disease Clin Transl Gastroenterol 11 e00157-373
- [9] Sanyal AJ(2008)A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH) Obes Surg 18 1430-11
- [10] Rinella ME(2020)FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study Lancet Gastroenterol Hepatol 5 362-607